Chesson Labs | Products

Chesson Labs’ products are based on innovative patented and patent-pending polymer chemistry. Our products cleared for market and in development include treatments for use by consumers and medical professionals.

Liquid Bandage Product

Chesson Labs Liquid Bandage is an innovative new health care product. The product’s FDA 510(k) clearance allows the Company to market and sell the product for use by healthcare professionals and directly to consumers. The product’s FDA cleared claims are to cover intact skin or minor cuts, scrapes, burns and minor irritations of the skin, to help keep them clean and dry and help protect them from infection. Chesson Labs Liquid Bandage will initially be marketed to the United States Military and medical professionals.

NUVADERM First Aid is a liquid bandage product for use by medics and personnel in the United States Armed Forces.

NSN# 6510-01-586-6314

For more information please visit http://www.NUVADERM.com

NUVADERM is a liquid bandage product for use by medical professionals and consumers.

For more information and ordering, please visit http://www.NUVADERM.com.

NUVAVET is an Animal Healthcare Bandage.

For more information and ordering, please visit www.NUVAVET.com

NAIL FUNGUS TREATMENT

Chesson Labs Nail Fungus Treatment is a biocompatible topical product for use in the management of mild to moderate Onychomycosis. Onychomycosis, commonly referred to as toenail fungus, is a disease which currently affects an estimated 35-40 million Americans, and more than 8% of the world’s population. The product is a polymer which is applied in liquid form with a foam applicator directly to the nail. Chesson Labs recently completed a clinical trial to evaluate the safety and effectiveness of its Nail Fungus Treatment.

(The claims and uses for this product have not been cleared by the FDA)

The Dutch Healthcare Inspectorate (IGZ) has been notified, and Chesson Labs has met the requirements of Article 14 of the Medical Devices Directive, 93/42/EEC. LIQUICURE® has been CE Marked as a Class I Medical Device in Europe.

For more information, please visit www.LIQUICURE.com (Coming Soon)

Research and Development

Through relationships with East Carolina University and leading U.S. based service providers, Chesson Labs has access to world class resources that are fueling the growth and the future of Chesson Labs. The Company sees additional uses for its current and future technology though internal funding, partnerships with other organizations, and grants. The Company will continue to develop new and novel products that will not only add value to the Company, but that will also continue to help people.


	Products About Us \| Management \| Products \| Partnerships \| News \| Investors Home \| Contact \| Legal
	Chesson Labs’ products are based on innovative patented and patent-pending polymer chemistry. Our products cleared for market and in development include treatments for use by consumers and medical professionals. Liquid Bandage Product Chesson Labs Liquid Bandage is an innovative new health care product. The product’s FDA 510(k) clearance allows the Company to market and sell the product for use by healthcare professionals and directly to consumers. The product’s FDA cleared claims are to cover intact skin or minor cuts, scrapes, burns and minor irritations of the skin, to help keep them clean and dry and help protect them from infection. Chesson Labs Liquid Bandage will initially be marketed to the United States Military and medical professionals. NUVADERM First Aid is a liquid bandage product for use by medics and personnel in the United States Armed Forces. NSN# 6510-01-586-6314 For more information please visit http://www.NUVADERM.com NUVADERM is a liquid bandage product for use by medical professionals and consumers. For more information and ordering, please visit http://www.NUVADERM.com. NUVAVET is an Animal Healthcare Bandage. For more information and ordering, please visit www.NUVAVET.com NAIL FUNGUS TREATMENT Chesson Labs Nail Fungus Treatment is a biocompatible topical product for use in the management of mild to moderate Onychomycosis. Onychomycosis, commonly referred to as toenail fungus, is a disease which currently affects an estimated 35-40 million Americans, and more than 8% of the world’s population. The product is a polymer which is applied in liquid form with a foam applicator directly to the nail. Chesson Labs recently completed a clinical trial to evaluate the safety and effectiveness of its Nail Fungus Treatment. (The claims and uses for this product have not been cleared by the FDA) The Dutch Healthcare Inspectorate (IGZ) has been notified, and Chesson Labs has met the requirements of Article 14 of the Medical Devices Directive, 93/42/EEC. LIQUICURE® has been CE Marked as a Class I Medical Device in Europe. For more information, please visit www.LIQUICURE.com (Coming Soon) Research and Development Through relationships with East Carolina University and leading U.S. based service providers, Chesson Labs has access to world class resources that are fueling the growth and the future of Chesson Labs. The Company sees additional uses for its current and future technology though internal funding, partnerships with other organizations, and grants. The Company will continue to develop new and novel products that will not only add value to the Company, but that will also continue to help people.